Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Streptococcus" wg kryterium: Temat


Wyświetlanie 1-3 z 3
Tytuł:
Number of Streptococcus mutans and Lactobacillus in saliva versus the status of cigarette smoking, considering duration of smoking and number of cigarettes smoked daily
Autorzy:
Nakonieczna-Rudnicka, Marta
Bachanek, Teresa
Powiązania:
https://bibliotekanauki.pl/articles/991053.pdf
Data publikacji:
2017
Wydawca:
Instytut Medycyny Wsi
Tematy:
streptococcus mutans
lactobacillus
cotinine
smoking
Opis:
Introduction and objective. A large number of colonies of Streptococcus mutans (SM) and Lactobacillus (LB) cariogenic bacteria in the saliva show a high risk of dental caries development. Cotinine is a biomarker of exposure to the tobacco smoke. The aim of the study was assessment of the number of Streptococcus mutans and Lactobacillus in the saliva of nonsmokers and smokers considering the duration of smoking and the number of cigarettes smoked daily. The number of SM and LB was analysed in relation to the frequency of oral health check-ups. Materials and method. The investigated group comprised 124 people aged 20–54. 58 (46.8%) reported cigarette smoking; 66 (53.2%) reported they had never smoked cigarettes and had never attempted to smoke. Cotinine concentration in the saliva was assayed using the Cotinine test (Calbiotech), and the number of SM and LB with the use of the CRT bacteria test (Ivoclar Vivadent, Liechtenstein). Statistical analysis was conducted using Chi2 and Mann-Whitney tests. Test values of p<0.05 were considered statistically significant. Results. No essential correlation was stated between the number of SM and LB and the status of smoking, the number of cigarettes smoked daily and duration of cigarette smoking. Smokers who reported having dental check-ups at least once a year significantly more frequently had a small number of LB stated in relation to people who had dental check-ups to control their oral health less frequently than once a year. Conclusion. The number of SM and LB in saliva does not depend on the smoking status, the number of cigarettes smoked daily and duration of smoking.
Źródło:
Annals of Agricultural and Environmental Medicine; 2017, 24, 3
1232-1966
Pojawia się w:
Annals of Agricultural and Environmental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part I - epidemiology
Autorzy:
Dutkiewicz, Jacek
Sroka, Jacek
Zając, Violetta
Wasiński, Bernard
Cisak, Ewa
Sawczyn, Anna
Kloc, Anna
Wójcik-Fatla, Angelina
Powiązania:
https://bibliotekanauki.pl/articles/991187.pdf
Data publikacji:
2017
Wydawca:
Instytut Medycyny Wsi
Tematy:
streptococcus suis
pigs
humans
carriage
disease
epidemiology
treatment
prevention
Opis:
Streptococcus suis (ex Elliot 1966, Kilpper-Bälz & Schleifer 1987) is a facultatively anaerobic Gram-positive ovoid or coccal bacterium surrounded by a polysaccharide capsule. Based on the antigenic diversity of the capsule, S. suis strains are classified serologically into 35 serotypes. Streptococcus suis is a commensal of pigs, commonly colonizing their tonsils and nasal cavities, mostly in weaning piglets between 4–10 weeks of age. This species occurs also in cattle and other mammals, in birds and in humans. Some strains, mostly those belonging to serotype 2, are also pathogenic for pigs, as well as for other animals and humans. Meningitis is the primary disease syndrome caused by S. suis, both in pigs and in humans. It is estimated that meningitis accounted for 68.0% of all cases of human disease reported until the end of 2012, followed by septicaemia (including life-threatening condition described as ‘streptococcal toxic shock-like syndrome’ – STSLS), arthritis, endocarditis, and endophthalmitis. Hearing loss and/or vestibular dysfunction are the most common sequelae after recovery from meningitis caused by S. suis, occurring in more than 50% of patients. In the last two decades, the number of reported human cases due to S. suis has dramatically increased, mostly due to epidemics recorded in China in 1998 and 2005, and the fulminant increase in morbidity in the countries of south-eastern Asia, mostly Vietnam and Thailand. Out of 1,642 cases of S. suis infections identified between 2002–2013 worldwide in humans, 90.2% occurred in Asia, 8.5% in Europe and 1.3% in other parts of the globe. The human disease has mostly a zoonotic and occupational origin and occurs in pig breeders, abattoir workers, butchers and workers of meat processing facilities, veterinarians and meat inspectors. Bacteria are transmitted to workers by close contact with pigs or pig products, usually through contamination of minor cuts or abrasions on skin of hands and/or arms, or by pig bite. A different epidemiologic situation occurs in the Southeast Asian countries where most people become infected by habitual consumption of raw or undercooked pork, blood and offal products in the form of traditional dishes. Prevention of S. suis infections in pigs includes vaccination, improvement in pig-raising conditions, disinfection and/or fumigation of animal houses, and isolation of sick animals at the outbreak of disease. Prevention of human infections comprises: protection of skin from pig bite or injury with sharp tools by people occupationally exposed to pigs and pig products, prompt disinfection and dressing of wounds and abrasions at work, protection of the respiratory tract by wearing appropriate masks or repirators, consulting a doctor in the case of febrile illness after exposure to pigs or pork meat, avoidance of occupations associated with exposure to pigs and pork by immunocompomised people, avoidance of consumption of raw pork or pig blood, adequate cooking of pork, and health education.
Źródło:
Annals of Agricultural and Environmental Medicine; 2017, 24, 4
1232-1966
Pojawia się w:
Annals of Agricultural and Environmental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part II – pathogenesis
Autorzy:
Dutkiewicz, J.
Zając, V.
Sroka, J.
Wasiński, B.
Cisak, E.
Sawczyn, A.
Kloc, A.
Wojcik-Fatla, A.
Powiązania:
https://bibliotekanauki.pl/articles/2081593.pdf
Data publikacji:
2018
Wydawca:
Instytut Medycyny Wsi
Tematy:
Streptococcus suis
pathogenesis
infection stages
interaction with host cells and tissues
virulence factors
genomic
determinants of pathogenicity
biofilm formation
Opis:
Abstract Streptococcus suis is a re-emerging zoonotic pathogen that may cause severe disease, mostly meningitis, in pigs and in humans having occupational contact with pigs and pork, such as farmers, slaughterhose workers and butchers. The first stage of the pathogenic process, similar in pigs and humans, is adherence to and colonisation of mucosal and/or epithelial surface(s) of the host. The second stage is invasion into deeper tissue and extracellular translocation of bacterium in the bloodstream, either free in circulation or attached to the surface of monocytes. If S. suis present in blood fails to cause fatal septicaemia, it is able to progress into the third stage comprising penetration into host’s organs, mostly by crossing the blood-brain barrier and/or blood–cerebrospinal fluid barrier to gain access to the central nervous system (CNS) and cause meningitis. The fourth stage is inflammation that plays a key role in the pathogenesis of both systemic and CNS infections caused by S. suis. The pathogen may induce the overproduction of pro-inflammatory cytokines that cause septic shock and/or the recruitment and activation of different leukocyte populations, causing acute inflammation of the CNS. Streptococcus suis can also evoke – through activation of microglial cells, astrocytes and possibly other cell types – a fulminant inflammatory reaction of the brain which leads to intracranial complications, including brain oedema, increased intracranial pressure, cerebrovascular insults, and deafness, as a result of cochlear sepsis. In all stages of the pathogenic process, S. suis interacts with many types of immunocompetent host’s cells, such as polymorphonuclear leukocytes, mononuclear macrophages, lymphocytes, dendritic cells and microglia, using a range of versatile virulence factors for evasion of the innate and adaptive immune defence of the host, and for overcoming environmental stress. It is estimated that S. suis produces more than 100 different virulence factors that could be classified into 4 groups: surface components or secreted elements, enzymes, transcription factors or regulatory systems and transporter factors or secretion systems. A major virulence factor is capsular polysaccharide (CPS) that protects bacteria from phagocytosis. However, it hampers adhesion to and invasion of host’s cells, release of inflammatory cytokines and formation of the resistant biofilm which, in many cases, is vital for the persistence of bacteria. It has been demonstrated that the arising by mutation unencapsulated S. suis clones, which are more successful in penetration to and propagation within the host’s cells, may coexist in the organism of a single host together with those that are encapsulated. Both ‘complementary’ clones assist each other in the successful colonization of host’s tissues and persistence therein. S. suis has an open pan-genome characterized by a frequent gene transfer and a large diversity. Of the genetic determinants of S. suis pathogenicity, the most important are pathogenicity islands (PAI), in particular, a novel DNA segment of 89 kb length with evident pathogenic traits that has been designated as 89K PAI. It has been estimated that more than one-third of the S. suis virulence factors is associated with this PAI. It has been proved that the virulent S. suis strains possess smaller genomes, compared to avirulent ones, but more genes associated with virulence. Overall, the evolution of the species most probably aims towards increased pathogenicity, and hence the most significant task of the current research is an elaboration of a vaccine, efficient both for humans and pigs.
Źródło:
Annals of Agricultural and Environmental Medicine; 2018, 25, 1; 186-203
1232-1966
Pojawia się w:
Annals of Agricultural and Environmental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies